Physician profile
Paramvir S Bains
NPI 1093990335
$630.85
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $78.65 · 2020: $46.22 · 2021: $16.47 · 2023: $244 · 2024: $246.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $490.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $489.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $345.65 | 2019-2024 | Xarelto |
| Cumberland Pharmaceuticals, INC. | $88.60 | 2023-2024 | Vibativ, Caldolor |
| Novartis Pharmaceuticals Corporation | $71.14 | 2020-2024 | |
| Astrazeneca Pharmaceuticals LP | $33.32 | 2023 | Brilinta |
| E.R. Squibb & Sons, L.L.C. | $28.06 | 2020-2024 | Eliquis |
| Pfizer INC. | $22.68 | 2019 | |
| Amgen INC. | $15.14 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.57 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $11.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paramvir Bains listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.